arrow
R

Richard A. Mularski

Kaiser Permanente Center for Health Research
H指数:52
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Household Transmission of SARS-CoV-2 in Washington and Oregon, United States, 2022-2024

2022-2024年美国华盛顿州和俄勒冈州的家庭内SARS-CoV-2传播

2026-07-200
PRE
INFLUENZA HOUSEHOLD TRANSMISSION AND GENOMIC DIVERSITY IN THE UNITED STATES: A PROSPECTIVE COHORT STUDY, 2022-2024

美国流感家庭传播及基因组多样性:一项前瞻性队列研究,2022-2024

2026-04-200
OAAI
Rationale and Design of the Roflumilast or Azithromycin to Prevent COPD Exacerbations Clinical Trial

罗氟司特或阿奇霉素预防COPD急性加重的临床试验的合理性与设计

2026-01-010
PRE
Less Versus More Intensive Surveillance of Pulmonary Nodules Detected Incidentally or by Screening: A Survey of Radiologist Beliefs About Guidelines Implemented in the Watch the Spot Trial

低强度与高强度肺结节监测:对“Watch the Spot”试验中实施的指南的放射科医师信念调查

2025-12-010
PRE
Correlates of risk of respiratory syncytial virus disease: a prospective cohort study

呼吸道合胞病毒疾病风险的关联因素:一项前瞻性队列研究

2025-09-260
OAAI
Parental intent to vaccinate children with the updated 2023–2024 COVID-19 vaccine

家长为孩子接种更新版2023–2024年COVID-19疫苗的意愿

Vaccine
IF3.5
2025-08-230
PRE
Baseline Characteristics of Participants and Pulmonary Nodules in the Watch the Spot Trial: A Pragmatic Trial of Less versus More Intensive Strategies for Active Surveillance of Patients With Small Pulmonary Nodules

参与者和肺结节的基线特征:一项关于对小型肺结节患者主动监测采用低强度与高强度策略的实用试验,Watch the Spot试验

2025-05-240
PRE
Household Transmission and Genomic Diversity of Respiratory Syncytial Virus (RSV) in the United States, 2022-2023
2025-03-010
PRE
Sustained Clinical Benefits of Spiration Valve System in Patients with Severe Emphysema
2024-02-015
OAAI
A New Global Definition of Acute Respiratory Distress Syndrome

一种新的全球急性呼吸窘迫综合征定义

2024-01-01171
PRE
Emotional Distress, Anxiety, and General Health Status in Patients With Newly Identified Small Pulmonary Nodules Results From the Watch the Spot Trial
CHEST
IF8.6
2023-12-018
PRE
Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive Coronavirus Disease 2019 Treatment Trial (ACTT) as a Test Case
2023-05-271
OA
Safety, tolerability, and immunogenicity of a 21-valent pneumococcal conjugate vaccine, V116, in healthy adults: phase 1/2, randomised, double-blind, active comparator- controlled, multicentre, US-based trial
2023-02-0137
PRE
Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment Trial
2022-12-014
OA
Palliative Care Early in the Care Continuum among Patients with Serious Respiratory Illness An Official ATS/AAHPM/HPNA/SWHPN Policy Statement
2022-09-1545
OAAI
Web-Based Mindfulness-Based Interventions for Well-being: Randomized Comparative Effectiveness Trial
2022-09-126
OAAI